サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1702349

ヘルスケアにおけるアイトラッキングの世界市場：2025年～2033年

Global Eye Tracking in Healthcare Market - 2025-2033

出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ヘルスケアにおけるアイトラッキングの世界市場：2025年～2033年
出版日: 2025年04月10日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のヘルスケアにおけるアイトラッキングの市場規模は、2024年に8億287万米ドルに達し、2033年には51億5,583万米ドルに達するとみられ、2025年～2033年の予測期間中にCAGR 21.4％で成長すると予測されています。

世界のヘルスケアにおけるアイトラッキング市場は、診断ツールから医療機器やアプリケーションにおけるユーザーエクスペリエンスの改善に至るまで、ヘルスケア提供の様々な側面を強化するためにアイトラッキング技術を活用しています。アイトラッキングは人の目の動きと焦点を測定し、神経学的評価、認知障害診断、リハビリ治療に貴重なデータを提供します。

この技術は、脳卒中、認知症、視覚障害などの状態を検出するために目の動きをモニターするために使用されるだけでなく、ADHDや自閉症スペクトラム障害のようなメンタルヘルス状態についての洞察も提供します。患者がどこにどのように焦点を合わせているかを追跡することで、ヘルスケア専門家は認知および神経学的健康についてより深い理解を得ることができ、より正確な治療と診断につながります。

神経および認知障害の有病率の上昇は、世界のヘルスケアにおけるアイトラッキング市場における主要な促進要因です。アルツハイマー病、パーキンソン病、脳卒中、自閉症スペクトラム（ASD）などの神経疾患や認知疾患が一般的になるにつれ、アイトラッキング技術のような革新的な診断・モニタリングツールの需要が高まっています。

アイトラッキングは、目の動きを分析することにより、これらの障害に関する貴重な洞察を提供し、初期徴候の特定や、より正確な診断に役立ちます。例えば、世界保健機関（WHO）の推計によると、世界中で約5,000万人が認知症を患っており、その数は2030年までに8,200万人に増加すると予想されています。また、パーキンソン病は世界で約1,000万人が罹患しています。これらの数字は、ヘルスケア分野におけるより良い診断ツールの緊急の必要性を強調しています。

アイトラッキングは、神経機能の評価、認知機能の早期の変化の検出、経時的な病気の進行をモニターする非侵襲的な方法の提供において、重要な役割を果たすことができます。世界の人口が高齢化し、認知障害の発生率が増加する中、アイトラッキング技術は、患者ケアの改善と治療成果の向上を目指す臨床医にとって不可欠なツールとなりつつあります。これら全ての要因が、ヘルスケアにおける世界のアイトラッキング市場の需要となっています。

機器と導入にかかるコストが高いことが、世界のヘルスケアにおけるアイトラッキング市場において大きな抑制要因となっており、特にヘルスケア環境においてこの技術が広く採用されることを制限しています。特に医療診断や神経学的評価のために設計されたアイトラッキングシステムは、ハイエンドのセンサー、特殊なソフトウェア、高度なハードウェアコンポーネントを含むことが多く、高価格となります。

例えば、神経疾患や認知障害に関連する微妙な目の動きを検出できる臨床グレードのシステムは、機器とそれをサポートするインフラの両方に多額の投資を必要とします。アイトラッキングシステムの1,001～10,000米ドルという価格帯は、特定の用途には適しているもの、より高度なヘルスケア診断に必要とされる精度や信頼性の基準を満たしていない可能性があるため、ヘルスケアにおけるアイトラッキングの世界市場において抑制要因として働く可能性があります。したがって、上記の要因がヘルスケアにおけるアイトラッキングの世界市場の潜在的成長を制限している可能性があります。

当レポートでは、世界のヘルスケアにおけるアイトラッキング市場について調査し、市場の概要とともに、タイプ別、トラッキングタイプ別、コンポーネント別、用途別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場のイントロダクションと範囲

第2章 経営者の洞察と重要なポイント

第3章 市場力学

  • 影響要因
    • 促進要因
    • 抑制要因
    • 機会
    • 影響分析

第4章 戦略的洞察と業界展望

  • 市場のリーダーとパイオニア
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向
  • キーオピニオンリーダー

第5章 ヘルスケアにおけるアイトラッキング市場（タイプ別）

  • 眼電図検査（EOG）
    • トラッキング
  • 光学追跡
  • 視線追跡

第6章 ヘルスケアにおけるアイトラッキング市場（トラッキングタイプ別）

  • リモートトラッキング
  • モバイルトラッキング

第7章 ヘルスケアにおけるアイトラッキング市場（コンポーネント別）

  • ハードウェア
  • ソフトウェア

第8章 ヘルスケアにおけるアイトラッキング市場（用途別）

  • 医療研究と診断
  • 支援技術
  • 認知神経学研究
  • 眼科学と視覚科学

第9章 ヘルスケアにおけるアイトラッキング市場（エンドユーザー別）

  • 医療機関
  • 研究機関
  • 補助器具メーカー

第10章 ヘルスケアにおけるアイトラッキング市場、地域別市場分析と成長機会

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他
  • 中東・アフリカ

第11章 競合情勢と市場ポジショニング

  • 競合状況の概要と主要市場参入企業
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併・買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第12章 企業プロファイル

  • Tobii
    • 会社概要
    • 製品ポートフォリオ
    • 財務概要
    • 主な発展
    • SWOT分析
  • SR Research Ltd.
  • iMotions
  • Gazepoint
  • EyeTech Digital Systems, Inc.
  • Pupil Labs GmbH.
  • EyeTracking
  • Smart Eye
  • Lumen
  • ERGONEERS GmbH

第13章 仮定と調査手法

第14章 付録

目次
Product Code: MD9433

The global eye tracking in healthcare market reached US$ 802.87 million in 2024 and is expected to reach US$ 5,155.83 million by 2033, growing at a CAGR of 21.4 % during the forecast period of 2025-2033.

The global eye tracking in healthcare market leverages eye tracking technology to enhance various aspects of healthcare delivery, ranging from diagnostic tools to improving the user experience in medical devices and applications. Eye tracking measures the movement and focus of a person's eyes, providing valuable data for neurological assessments, cognitive disorder diagnoses, and rehabilitation therapy.

This technology is used to monitor eye movements for the detection of conditions such as stroke, dementia, and visual impairments, while also offering insights into mental health conditions like ADHD or autism spectrum disorders. By tracking where and how patients focus, healthcare professionals gain a deeper understanding of cognitive and neurological health, leading to more precise treatments and diagnoses.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Neurological and Cognitive Disorders

The rising prevalence of neurological and cognitive disorders is a key driver in the global eye tracking in healthcare market. As neurological and cognitive conditions such as Alzheimer's disease, Parkinson's disease, stroke, and autism spectrum disorders (ASD) become more common, the demand for innovative diagnostic and monitoring tools, such as eye tracking technology, is increasing.

Eye tracking offers valuable insights into these disorders by analyzing eye movements, helping to identify early signs and aiding in more accurate diagnoses. For instance, the World Health Organization estimates that approximately 50 million people worldwide suffer from dementia, and the number is expected to rise to 82 million by 2030. Additionally, Parkinson's disease affects about 10 million people globally. These numbers underscore the urgent need for better diagnostic tools in the healthcare sector.

Eye tracking can play a critical role in assessing neurological function, detecting early changes in cognition, and offering a non-invasive way to monitor disease progression over time. As the global population ages and the incidence of cognitive disorders increases, eye tracking technology is becoming an essential tool for clinicians aiming to improve patient care and enhance treatment outcomes. All these factors demand global eye tracking in the healthcare market.

High Costs of Equipment and Implementation

The high costs of equipment and implementation pose a significant restraint in the global eye tracking in healthcare market, limiting the widespread adoption of this technology, especially in healthcare settings. Eye tracking systems, particularly those designed for medical diagnostics or neurological assessments, often involve high-end sensors, specialized software, and advanced hardware components that come at a steep price.

For instance, clinical-grade systems capable of detecting subtle eye movements associated with neurological diseases or cognitive disorders require significant investment in both equipment and the infrastructure to support them. The price range of $1.001 to $10,000 for eye tracking systems can act as a restraint in the global eye tracking in healthcare market because these systems, while suitable for certain applications, may not meet the precision and reliability standards required for more advanced healthcare diagnostics. Thus, the above factors could be limiting the global eye tracking in the healthcare market's potential growth.

Segment Analysis

The global eye tracking in healthcare market is segmented based on type, tracking type, component, application, end-user, and region.

Tracking Type:

The remote tracking segment in tracking type is expected to dominate the global eye tracking in healthcare market with the highest market share

The remote tracking segment of the global eye tracking in healthcare market leverages innovative technologies such as cloud computing, mobile devices, and wearable technologies to enable the monitoring of patients' eye movements outside traditional clinical settings.

This capability is crucial in telemedicine platforms, mobile health apps, and home-based monitoring systems. By allowing healthcare providers to track patients from a distance, remote eye tracking can be especially beneficial for continuous monitoring of those with neurological conditions, cognitive disorders, or individuals undergoing rehabilitation therapies.

It eliminates the need for patients to visit healthcare facilities regularly, improving access to care and enhancing patient convenience. This is especially important as patients, particularly those with chronic conditions, can experience fluctuations in symptoms that require consistent tracking.

By enabling eye movement analysis outside of medical environments, remote tracking technology offers greater flexibility in patient care and supports early detection of changes in cognitive or neurological health. It also allows for real-time data collection, making it easier to adjust treatment plans or interventions based on immediate insights. These factors have solidified the segment's position in the global eye tracking in healthcare market.

Geographical Analysis

North America is expected to hold a significant position in the global eye tracking in healthcare market, with the highest market share

The North American eye tracking in healthcare market is being driven by several factors. One of the key drivers is the increasing application of eye tracking technology in the healthcare sector, particularly for diagnosing and monitoring neurological disorders like Parkinson's disease, Alzheimer's, and other cognitive impairments. This technology provides valuable insights into eye movements and gaze patterns, which help in early detection and assessment, enhancing the effectiveness of treatment and rehabilitation.

Furthermore, North America's advanced healthcare system and technological infrastructure play a significant role in driving the market. The region is home to leading research institutions and healthcare providers that integrate eye tracking into clinical practices, such as in cognitive rehabilitation and assistive devices for patients with severe motor disabilities.

The region is also seeing increased adoption in consumer electronics, gaming, and the automotive industry, all of which are contributing to the broader use of eye tracking in healthcare settings. Thus, the above factors are consolidating the region's position as a dominant force in the global eye tracking in healthcare market.

Competitive Landscape

The major global players in the eye tracking in healthcare market include Tobii, SR Research Ltd., iMotions, Gazepoint, EyeTech Digital Systems, Inc., Pupil Labs GmbH, EyeTracking, Smart Eye, Lumen, and ERGONEERS GmbH, among others.

Key Developments

  • In February 2024, Visage Imaging, Inc. unveiled the innovative Visage Ease VP for Apple Vision Pro, Apple's much-awaited spatial computing platform. Tailored to leverage the distinct features of Apple Vision Pro, Visage Ease VP enables immersive, spatial interactions for diagnostic imaging and multimedia applications.
  • In January 2024, Tobii's launch of the UX Explore cloud platform, designed to enhance mobile user experience (UX) research with eye-tracking technology, is a significant development that could positively impact the global eye-tracking in healthcare market. This cloud-based solution allows for more scalable, efficient, and accessible UX research, enabling healthcare professionals and developers to evaluate the user experience of mobile healthcare applications, telemedicine platforms, and digital health devices with greater ease.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzed product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global eye tracking in healthcare market report delivers a detailed analysis with 78 key tables, more than 71 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Tracking Type
  • 2.5. Snippet by Component
  • 2.6. Snippet by Application
  • 2.7. Snippet by End-User
  • 2.8. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Neurological and Cognitive Disorders
      • 3.1.1.2. Advancements in Eye Tracking Technology
    • 3.1.2. Restraints
      • 3.1.2.1. High Costs of Equipment and Implementation
      • 3.1.2.2. Privacy and Data Security Concerns
    • 3.1.3. Opportunity
      • 3.1.3.1. Integration with Virtual Reality (VR) and Augmented Reality (AR)
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with the largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Forces Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Eye Tracking in Healthcare Market, By Type

  • 5.1. Introduction
    • 5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. Electrooculography (EOG)*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 5.2.3. Tracking
  • 5.3. Optical Tracking
  • 5.4. Eye-Attached Tracking

6. Eye Tracking in Healthcare Market, By Tracking Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
    • 6.1.2. Market Attractiveness Index, By Tracking Type
  • 6.2. Remote Tracking*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Mobile Tracking

7. Eye Tracking in Healthcare Market, By Component

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 7.1.2. Market Attractiveness Index, By Component
  • 7.2. Hardware*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Software

8. Eye Tracking in Healthcare Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Medical Research & Diagnostics*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Assistive Technology
  • 8.4. Cognitive & Neurological Studies
  • 8.5. Ophthalmology & Vision Science

9. Eye Tracking in Healthcare Market, By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Healthcare Providers*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Research Institutes
  • 9.4. Assistive Device Manufacturers

10. Eye Tracking in Healthcare Market, By Regional Market Analysis and Growth Opportunities

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.8.1. U.S.
      • 10.2.8.2. Canada
      • 10.2.8.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.8.1. Germany
      • 10.3.8.2. U.K.
      • 10.3.8.3. France
      • 10.3.8.4. Spain
      • 10.3.8.5. Italy
      • 10.3.8.6. Rest of Europe
  • 10.4. Latin America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.8.1. Brazil
      • 10.4.8.2. Argentina
      • 10.4.8.3. Rest of Latin America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.8.1. China
      • 10.5.8.2. India
      • 10.5.8.3. Japan
      • 10.5.8.4. South Korea
      • 10.5.8.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape and Market Positioning

  • 11.1. Competitive Overview and Key Market Players
  • 11.2. Market Share Analysis and Positioning Matrix
  • 11.3. Strategic Partnerships, Mergers & Acquisitions
  • 11.4. Key Developments in Product Portfolios and Innovations
  • 11.5. Company Benchmarking

12. Company Profiles

  • 12.1. Tobii*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals, etc.
    • 12.1.5. SWOT Analysis
  • 12.2. SR Research Ltd.
  • 12.3. iMotions
  • 12.4. Gazepoint
  • 12.5. EyeTech Digital Systems, Inc.
  • 12.6. Pupil Labs GmbH.
  • 12.7. EyeTracking
  • 12.8. Smart Eye
  • 12.9. Lumen
  • 12.10. ERGONEERS GmbH

LIST NOT EXHAUSTIVE

13. Assumptions and Research Methodology

  • 13.1. Data Collection Methods
  • 13.2. Data Triangulation
  • 13.3. Forecasting Techniques
  • 13.4. Data Verification and Validation

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us